1315 Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Spineology develops minimally invasive spine surgery implants, including its flagship OptiMesh interbody fusion technology that delivers a bone graft-containing implant through a small surgical portal.
BiotechHardwareHealthtechMedical DevicesSt. Paul, US
Stephen D. Kuslich(Founder)JAMISON YOUNG(Executive Officer)inBrian Snider(Chief Executive Officer & Board Member)inSteve Nemitz(Chief Financial Officer)inAmanda Bloom(Executive Vice President, Marketing)inEmory Rooney(Executive Vice President, Sales)in
Board seatCraig Matturro· per SEC Form D
Co-investorsRC CapitalSV Health Investors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




